المؤلفون: Malcolm David Mason, Martin J. Russell, Daniel M. Aebersold, Mahesh K. B. Parmar, Clare Gilson, David Matheson, Simon Chowdhury, Robert Jones, Silke Gillessen, William Cross, Hassan Douis, Adnan Ali, Alex Hoyle, Gerhardt Attard, A.W.S. Ritchie, Christopher D. Brawley, Johann S. de Bono, Chris Parker, David P. Dearnaley, Fiona C. Ingleby, Noel W. Clarke, Adrian Cook, Matthew R. Sydes, Nicholas D. James, Robin Millman

المصدر: European Urology. 76:719-728

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, Hazard ratio, 030232 urology & nephrology, Abiraterone acetate, Subgroup analysis, medicine.disease, Confidence interval, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, medicine, Number needed to treat, Hormone therapy, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5eaa0bfa0b25d6df5c26f27c1825bab5
https://doi.org/10.1016/j.eururo.2019.08.006

المؤلفون: Tim Eisen, Bhavna Oza, Joaquim Bellmunt, Axel Bex, Janet E. Brown, Mahesh K. B. Parmar, Martin R. Stockler, Richard Kaplan, Barry W. Hancock, Ian D. Davis, Gregers G. Hermann, James Larkin, Steven Joniau, A.W.S. Ritchie, Jim Barber, Rhona McMenemin, Lisa Pickering, Angela M. Meade, Paul Nathan, Eleni Frangou, Elizabeth Hodgkinson, Bernard Escudier, Grant D. Stewart, Benjamin Smith, Laurence Albiges

المساهمون: Frangou, Eleni [0000-0002-5978-292X], Kaplan, Rick [0000-0002-0189-8348], Davis, Ian D [0000-0002-9066-8244], Larkin, James [0000-0001-5569-9523], Joniau, Steven [0000-0003-3195-9890], Hermann, Gregers G [0000-0002-8413-5919], Bellmunt, Joaquim [0000-0003-2328-3421], Stewart, Grant D [0000-0003-3188-9140], Parmar, Mahesh KB [0000-0003-0166-1700], Apollo - University of Cambridge Repository

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(34)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Sorafenib, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, urologic and male genital diseases, Disease-Free Survival, law.invention, Placebos, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Renal cell carcinoma, Risk Factors, Internal medicine, medicine, Carcinoma, Humans, Survival rate, neoplasms, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Chemotherapy, business.industry, Middle Aged, medicine.disease, female genital diseases and pregnancy complications, Kidney Neoplasms, Clinical trial, Survival Rate, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, Adjuvant, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7048e7916526f23d7c7a4d1385f9c71d
https://pubmed.ncbi.nlm.nih.gov/33874729

المؤلفون: Axel Bex, Eleni Frangou, Barry W. Hancock, Laurence Albiges, Gregers G. Hermann, Angela M. Meade, Martin R. Stockler, Tim Eisen, Ian D. Davis, Benjamin Smith, Elizabeth Hodgkinson, Bernard Escudier, M.K.B. Parmar, Bhavna Oza, Joaquim Bellmunt, P. Hanlon, J.M.G. Larkin, Steven Joniau, A.W.S. Ritchie, Richard Kaplan

المصدر: Annals of Oncology. 30:v891-v892

مصطلحات موضوعية: 0301 basic medicine, Drug supply, Sorafenib, medicine.medical_specialty, Standard of care, business.industry, education, Stock options, Hematology, Double blind, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Mean Survival Time, Family medicine, Medicine, Relapse risk, business, health care economics and organizations, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::aa42131a8be01d521fca3f28b57ef30d
https://doi.org/10.1093/annonc/mdz394.050

المؤلفون: Janet E. Brown, J.M. Russell, Hassan Douis, Adrian Cook, Matthew R. Sydes, David Matheson, Narayanan Srihari, Alex Hoyle, Matthew S. Simms, A. Nikapota, Anjali Zarkar, Christopher D. Brawley, F.C. Ingleby, Noel W. Clarke, J. Calvert, John Wagstaff, Duncan C. Gilbert, Gerhardt Attard, Jacob Tanguay, A.W.S. Ritchie, Adnan Ali, Ruth E Langley, Andrew Protheroe, Aurelius Omlin, H. Rush, Anna Lydon, David P. Dearnaley, Malcolm David Mason, James D. Wylie, Silke Gillessen, Simon Chowdhury, L. Capaldi, Sharon Beesley, Joe M O'Sullivan, Mona Parmar, Omi Parikh, Joanna Gale, Jan Wallace, S. Rudman, Chris Parker, Alison Birtle, Archie Macnair, Claire Amos, Stephanie Gibbs, Robin Millman, Robert Jones, Zafar Malik, William Cross, Nicholas D. James, Shaun Tolan

المصدر: STAMPEDE Investigators 2019, ' Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial ', Annals of Oncology . https://doi.org/10.1093/annonc/mdz396
Annals of Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, STAMPEDE trial, 0302 clinical medicine, Urogenital Tumors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, hormone naive, medicine, Humans, docetaxel, Progression-free survival, Neoplasm Metastasis, Disease burden, Aged, Proportional Hazards Models, Retrospective Studies, Manchester Cancer Research Centre, business.industry, Proportional hazards model, ResearchInstitutes_Networks_Beacons/mcrc, Prostatic Neoplasms, Androgen Antagonists, Retrospective cohort study, Hematology, Original Articles, Middle Aged, medicine.disease, prostate cancer, Progression-Free Survival, metastatic, 030104 developmental biology, Docetaxel, randomised control trial, 030220 oncology & carcinogenesis, Disease Progression, Hormonal therapy, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae50219cab2735395675e6bd870c6e64
https://doi.org/10.1093/annonc/mdz396

المؤلفون: Duncan C. Gilbert, Joanna Gale, Nicholas D. James, Shaun Tolan, Claire Amos, Robin Millman, Zafar Malik, G. Attard, James D. Wylie, Anjali Zarkar, S. Rudman, Robert Jones, Anna Lydon, Noel W. Clarke, Chris Parker, Joe M O'Sullivan, Jan Wallace, Aurelius Omlin, Alison Birtle, Adrian Cook, Archie Macnair, Malcolm David Mason, A.W.S. Ritchie, Matthew S. Simms, Alex Hoyle, Adnan Ali, H. Rush, John Wagstaff, Christopher D. Brawley, Jacob Tanguay, Andrew Protheroe, Silke Gillessen, Ruth E Langley, F.C. Ingleby, Omi Parikh, Stephanie Gibbs, David P. Dearnaley, David Matheson, Matthew R. Sydes, William Cross, Simon Chowdhury, L. Capaldi, Sharon Beesley, J. Calvert, Janet E. Brown, J.M. Russell, Hassan Douis, Narayanan Srihari, A. Nikapota, Mona Parmar, Stampede Investigators

المصدر: Annals of Oncology. 31:442

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, MEDLINE, Hematology, Hormone sensitive prostate cancer, Docetaxel, Internal medicine, Long term survival, medicine, Hormonal therapy, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::47b985e6be9b562abd6b7317e5eed22c
https://doi.org/10.1016/j.annonc.2020.01.002

المؤلفون: Alex Hoyle, Chris Parker, Nicholas D. James, Robert Jones, A. Cooke, Silke Gillessen, Martin J. Russell, G. Attard, J.S. de Bono, N.W. Clarke, Matthew R. Sydes, William Cross, David P. Dearnaley, Hassan Douis, M.K.B. Parmer, Clare Gilson, Simon Chowdhury, A.W.S. Ritchie, Adnan Ali, Malcolm David Mason, David Matheson

المصدر: European Urology Supplements. 18:e1387-e1388

مصطلحات موضوعية: chemistry.chemical_compound, medicine.medical_specialty, Hormone sensitive prostate cancer, chemistry, Prednisone, business.industry, Urology, Prednisolone, medicine, Abiraterone acetate, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0860dda1f65989e72c923caf9e18128e
https://doi.org/10.1016/s1569-9056(19)31004-8

المؤلفون: Ian D. Davis, Xanthi Coskinas, Shomik Sengupta, A.W.S. Ritchie, Richard Kaplan, Prunella Blinman, Martin R. Stockler, Angela M. Meade, Andrew J. Martin, Tim Eisen, S. Troon, Elizabeth Hovey

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 29(2)

مصطلحات موضوعية: Sorafenib, Oncology, Adult, Male, medicine.medical_specialty, Alpha interferon, Antineoplastic Agents, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Renal cell carcinoma, law, Internal medicine, Surveys and Questionnaires, Adjuvant therapy, Medicine, Humans, 030212 general & internal medicine, Carcinoma, Renal Cell, Aged, business.industry, Sunitinib, Patient Preference, Hematology, Middle Aged, medicine.disease, Kidney Neoplasms, Clinical trial, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2efb0a3f4b8f89d87e1b3be9a97d5ce
https://pubmed.ncbi.nlm.nih.gov/30412976

المؤلفون: A.W.S. Ritchie, Nicholas D. James, Matthew R. Sydes

المصدر: European urology. 72(1)

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, business.industry, Urology, 030232 urology & nephrology, Neutropenic fever, Prostatic Neoplasms, Docetaxel, 03 medical and health sciences, Hormone sensitive prostate cancer, 0302 clinical medicine, Attitude, 030220 oncology & carcinogenesis, Internal medicine, medicine, Humans, Taxoids, business, medicine.drug, Platinum

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4402c6c8c67a17791b25442dab22b8
https://pubmed.ncbi.nlm.nih.gov/27417033

المؤلفون: A Meade, Ian D. Davis, Prunella Blinman, Nicola Jane Lawrence, S. Troon, Timothy Eisen, Andrew J. Martin, Richard Kaplan, Xanthi Coskinas, Elizabeth Hovey, Martin R. Stockler, A.W.S. Ritchie, Shomik Sengupta

المصدر: Annals of Oncology. 28:v310-v311

مصطلحات موضوعية: 0301 basic medicine, Sorafenib, Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, Placebo, medicine.disease, Nephrectomy, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::23dad5857ff0b1462cd4e555683af423
https://doi.org/10.1093/annonc/mdx371.035

المؤلفون: Robert Jones, Adrian Cook, Noel W. Clarke, Malcolm David Mason, Sahirzeeshan Ali, Clare Gilson, Simon Chowdhury, Chris Parker, Silke Gillessen, A.W.S. Ritchie, Mona Parmar, Alex Hoyle, David P. Dearnaley, Nicholas D. James, William Cross, J.S. de Bono, Matthew R. Sydes, David Matheson, Gerhardt Attard, Martin J. Russell

المصدر: Annals of Oncology. 29:viii722

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, 030232 urology & nephrology, Abiraterone acetate, Hematology, medicine.disease, 03 medical and health sciences, Abiraterone, chemistry.chemical_compound, Prostate cancer, Hormone sensitive prostate cancer, 0302 clinical medicine, chemistry, Prednisone, 030220 oncology & carcinogenesis, Internal medicine, medicine, Prednisolone, business, medicine.drug, Hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ad368ed6fd0f6374d4ebcf08cf936ce5
https://doi.org/10.1093/annonc/mdy424.033